Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntuitive Inv Regulatory News (IIG)

Share Price Information for Intuitive Inv (IIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 130.00
Bid: 125.00
Ask: 135.00
Change: 0.00 (0.00%)
Spread: 10.00 (8.00%)
Open: 130.00
High: 130.00
Low: 130.00
Prev. Close: 130.00
IIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FORM 8.3 - Yourgene Health Plc

5 Jul 2023 15:46

RNS Number : 0952F
Intuitive Investments Group plc
05 July 2023
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Intuitive Investments Group Plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Yourgene Health Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

3 July 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

If YES, specify which:

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

0.1p Ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

51,584,920

1.62

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

51,584,920

1.62

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

5 July 2023

Contact name:

Robert Naylor

Telephone number*:

07738 784 593

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETRAMITMTIMBMJ
Date   Source Headline
8th Apr 20247:00 amRNSIssue and Allotment of Ordinary Shares
22nd Mar 20249:00 amRNSIIG celebrates Sir Nigel Rudd’s award win
21st Mar 20247:00 amRNSIssue and Allotment of Ordinary Shares
7th Mar 20247:00 amRNSHui10 contract win
29th Feb 202410:36 amRNSResult of AGM
28th Feb 20247:00 amRNSIssue of shares
27th Feb 20247:00 amRNSHui10 approved to expand with China Sports Lottery
16th Feb 20247:00 amRNSAppointment of Corporate Broker
6th Feb 202410:45 amRNSPosting of Annual Report and AGM Notice
1st Feb 20242:23 pmRNSTotal Voting Rights
31st Jan 20247:00 amRNSFinancial Results
4th Jan 20242:54 pmRNSIssue of shares
29th Dec 20237:00 amRNSTotal Voting Rights
12th Dec 20233:48 pmRNSIssue of shares
28th Nov 20237:00 amRNSUpdate to the Board of Directors
3rd Nov 20231:36 pmRNSDirector Dealing
1st Nov 202310:41 amRNSHolding(s) in Company
27th Oct 20231:33 pmRNSDirector Dealing
27th Oct 20237:00 amRNSInvestment in Hui10 Inc
31st Aug 20238:25 amRNSTotal Voting Rights
10th Aug 202311:08 amRNSHolding(s) in Company
8th Aug 20238:00 amRNSReadmission - Intuitive Investments Group plc
28th Jul 20233:35 pmRNSGM, Tender Offer & Placing & Directorate Change
13th Jul 20235:02 pmRNSForm 8.3 - Yourgene Health PLC - Correction
11th Jul 202310:47 amRNSNotice of General Meeting - Correction
11th Jul 20237:00 amRNSNotice of General Meeting to approve Proposals
11th Jul 20237:00 amRNSIIG appoints Sir Nigel Rudd as its next Chairman
5th Jul 20233:46 pmRNSFORM 8.3 - Yourgene Health Plc
29th Jun 20237:00 amRNSInterim report for the six months to 31 March 2023
31st May 20237:00 amRNSTotal Voting Rights
24th May 20237:00 amRNSReorganisation and Deferred Consideration
26th Apr 20234:57 pmRNSHolding(s) in Company
17th Jan 202311:19 amRNSResult of AGM and Directorate Change
11th Jan 202310:00 amRNSInvestment in Yourgene Health plc
21st Dec 20227:00 amRNSFinal Results
7th Nov 20222:05 pmRNSSecond Price Monitoring Extn
7th Nov 20222:00 pmRNSPrice Monitoring Extension
5th Aug 20227:00 amRNSInvestment in PneumoWave Limited
26th May 20227:00 amRNSUpdate on Sanondaf
25th May 20227:00 amRNSHalf-year Report
20th Apr 202211:13 amRNSDispensation from Rule 9 of the Code
4th Apr 202211:13 amRNSTotal Voting Rights
8th Mar 20223:39 pmRNSHolding(s) in Company
2nd Mar 20227:00 amRNSSubscription
25th Feb 202212:11 pmRNSInvestment & Appointment of Non-Executive Chair
14th Feb 202212:59 pmRNSChange of Registered Office
14th Feb 20227:00 amRNSInvestment in Ocutec Limited
24th Jan 20228:45 amRNSDirector Dealing
30th Dec 202110:58 amRNSResult of AGM
20th Dec 20217:00 amRNSChange of Registered Office

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.